Medline Inc.
corporate_fare Company Profile
Medline Inc. (NASDAQ:MDLN) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 47 items for MDLN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-18, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 10 rated 8 or above. Recent SEC coverage for MDLN spans 8-K, S-1, 10-Q, 4.
Recent high-impact activity:
- Medline Prices 60M-Share Secondary at $35.50; Company to Buy Back $200M
- Sponsors Price 60M-Share Medline Secondary at $35.50, a Discount to $37.51
- Sponsors Launch 60M-Share Secondary; Medline to Buy Back $200M Concurrently
- Medline Bed Death Toll Climbs to Seven After FDA Warning
- Medline Q3 Sales Rise 10.4% to $7.86B; Nine-Month Net Income Drops 28.8% on Fire and FDA Costs
Financial Snapshot
Short Interest & Short Volume
3.79 days to coverFINRA reported short interest of 37,840,814 shares in MDLN as of the October 30, 2026 settlement, a 7.3% decrease from the prior period — about 3.8 days to cover at its recent average daily volume. On November 20, 2026, 51.9% of MDLN volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Moderate riskFiling-implied dilution signals for MDLN, detected from its recent SEC filings · based on capital-structure filings through 2026-11-19.
Secondary Offering Finalized · No Proceeds to Company
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →